Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

V1RC25 Inhibitors

V1RC25 inhibitors constitute a specialized class of chemical compounds designed to interact with the V1RC25 protein. These inhibitors are distinguished by their intricate chemical architectures, which often feature a blend of aromatic and aliphatic structures, heterocycles, and diverse functional groups. The development of V1RC25 inhibitors involves a detailed understanding of the protein's binding sites and molecular interactions. Chemists leverage techniques such as molecular modeling and structure-activity relationship (SAR) studies to tailor these compounds for high specificity and efficacy in binding to the V1RC25 protein. The chemical synthesis of V1RC25 inhibitors is a complex process, incorporating advanced organic synthesis methodologies to produce compounds with precise structural features.

The design of V1RC25 inhibitors is guided by the need to achieve high selectivity and potency. The chemical class includes molecules with varied scaffolds, including small organic molecules and larger, more complex structures. These inhibitors are crafted to interact with the protein through multiple binding modes, which may include hydrogen bonding, hydrophobic interactions, and electrostatic forces. By employing iterative cycles of design, synthesis, and testing, researchers refine these compounds to enhance their interaction with V1RC25. This class of inhibitors exemplifies the intersection of chemistry and molecular biology, where detailed knowledge of protein structure informs the development of molecules that can modulate specific biological targets.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Silybin

22888-70-6sc-202812
sc-202812A
sc-202812B
sc-202812C
1 g
5 g
10 g
50 g
$54.00
$112.00
$202.00
$700.00
6
(1)

May interfere with molecular cascades involved in Vomeronasal 1 receptor 28 expression, potentially inhibiting it.

Fisetin

528-48-3sc-276440
sc-276440A
sc-276440B
sc-276440C
sc-276440D
50 mg
100 mg
500 mg
1 g
100 g
$51.00
$77.00
$102.00
$153.00
$2856.00
7
(1)

Exhibits anti-inflammatory effects and may interfere with signaling pathways associated with Vomeronasal 1 receptor 28 expression.

Ginkgolide B

15291-77-7sc-201037B
sc-201037
sc-201037C
sc-201037A
5 mg
10 mg
25 mg
50 mg
$45.00
$63.00
$112.00
$197.00
8
(1)

Found in Ginkgo biloba, ginkgolide B may modulate cellular pathways associated with Vomeronasal 1 receptor 28 expression, potentially inhibiting it.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$108.00
$245.00
$918.00
$49.00
33
(2)

Acts as a flavonoid, potentially inhibiting Vomeronasal 1 receptor 28 expression by interfering with relevant cellular signaling pathways.

Gingerol

23513-14-6sc-201519
sc-201519A
5 mg
20 mg
$107.00
$379.00
5
(1)

Exhibits anti-inflammatory properties and may interfere with cellular pathways involved in Vomeronasal 1 receptor 28 expression.

Baicalein

491-67-8sc-200494
sc-200494A
sc-200494B
sc-200494C
10 mg
100 mg
500 mg
1 g
$31.00
$41.00
$159.00
$286.00
12
(1)

Has been shown to modulate inflammatory responses, potentially impacting the expression of Vomeronasal 1 receptor 28.

Ellagic Acid, Dihydrate

476-66-4sc-202598
sc-202598A
sc-202598B
sc-202598C
500 mg
5 g
25 g
100 g
$57.00
$93.00
$240.00
$713.00
8
(1)

Exhibits antioxidant properties and may modulate signaling cascades involved in Vomeronasal 1 receptor 28 expression.

Naringin

10236-47-2sc-203443
sc-203443A
25 g
50 g
$44.00
$99.00
7
(1)

Acts as a flavonoid, potentially inhibiting Vomeronasal 1 receptor 28 expression by interfering with relevant cellular signaling pathways.

Linalool

78-70-6sc-250250
sc-250250A
sc-250250B
5 g
100 g
500 g
$46.00
$71.00
$108.00
(0)

Found in essential oils, linalool may interfere with cellular pathways associated with Vomeronasal 1 receptor 28 expression, potentially inhibiting it.

Cryptotanshinone

35825-57-1sc-280649
10 mg
$117.00
1
(1)

May interfere with molecular cascades involved in Vomeronasal 1 receptor 28 expression, potentially inhibiting it.